Citius Pharmaceuticals Inc expected to post a loss of 5 cents a share - Earnings Preview

Citius Pharmaceuticals

08/05/2024 12:19

* Citius Pharmaceuticals Inc  CTXR.OQ   CTXR.O  is expected
to show a rise in quarterly revenue when it reports  results on
May 10 (estimated) for the period ending March 31 2024
    * The Cranford New Jersey-based  company is expected to
report
revenue of $14.814 million, according to the mean estimate from
3 analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Citius Pharmaceuticals
Inc is
for a loss of 5 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Citius
Pharmaceuticals Inc is $4.00​, above​ its last closing price
of $0.68. ​​​

This summary was machine generated May 8 at 11:19 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)